Folgen
Seiichi Mori
Seiichi Mori
Genome Center, Japanese Foundation for Cancer Research
Bestätigte E-Mail-Adresse bei jfcr.or.jp
Titel
Zitiert von
Zitiert von
Jahr
Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2
Y Yokota, A Mansouri, S Mori, S Sugawara, S Adachi, SI Nishikawa, ...
Nature 397 (6721), 702-706, 1999
10321999
Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
TZ Tan, QH Miow, Y Miki, T Noda, S Mori, RYJ Huang, JP Thiery
EMBO molecular medicine 6 (10), 1279-1293, 2014
6602014
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
T Baba, PA Convery, N Matsumura, RS Whitaker, E Kondoh, T Perry, ...
Oncogene 28 (2), 209-218, 2009
5252009
A bistable Rb–E2F switch underlies the restriction point
G Yao, TJ Lee, S Mori, JR Nevins, L You
Nature cell biology 10 (4), 476-482, 2008
4982008
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor …
RYJ Huang, MK Wong, TZ Tan, KT Kuay, AHC Ng, VY Chung, YS Chu, ...
Cell death & disease 4 (11), e915-e915, 2013
4292013
Anchorage-independent cell growth signature identifies tumors with metastatic potential
S Mori, JT Chang, ER Andrechek, N Matsumura, T Baba, G Yao, JW Kim, ...
Oncogene 28 (31), 2796-2805, 2009
3882009
Role of Id family proteins in growth control
Y Yokota, S Mori
Journal of cellular physiology 190 (1), 21-28, 2002
3092002
An E2F1-dependent gene expression program that determines the balance between proliferation and cell death
TC Hallstrom, S Mori, JR Nevins
Cancer cell 13 (1), 11-22, 2008
2862008
The genomic analysis of lactic acidosis and acidosis response in human cancers
JLY Chen, JE Lucas, T Schroeder, S Mori, J Wu, J Nevins, M Dewhirst, ...
PLoS genetics 4 (12), e1000293, 2008
2302008
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
TZ Tan, QH Miow, RYJ Huang, MK Wong, J Ye, JA Lau, MC Wu, ...
EMBO molecular medicine 5 (7), 1051-1066, 2013
2172013
Lactation defect in mice lacking the helix–loop–helix inhibitor Id2
S Mori, SI Nishikawa, Y Yokota
The EMBO journal 19 (21), 5772-5781, 2000
1662000
Using a stem cell–based signature to guide therapeutic selection in cancer
I Shats, ML Gatza, JT Chang, S Mori, J Wang, J Rich, JR Nevins
Cancer research 71 (5), 1772-1780, 2011
1402011
A genomic strategy to elucidate modules of oncogenic pathway signaling networks
JT Chang, C Carvalho, S Mori, AH Bild, ML Gatza, Q Wang, JE Lucas, ...
Molecular cell 34 (1), 104-114, 2009
1392009
FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway
M Asad, MK Wong, TZ Tan, M Choolani, J Low, S Mori, D Virshup, ...
Cell death & disease 5 (7), e1346-e1346, 2014
1382014
A role for E2F6 in distinguishing G1/S-and G2/M-specific transcription
PH Giangrande, W Zhu, S Schlisio, X Sun, S Mori, S Gaubatz, JR Nevins
Genes & development 18 (23), 2941-2951, 2004
1362004
Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
QH Miow, TZ Tan, J Ye, JA Lau, T Yokomizo, JP Thiery, S Mori
Oncogene 34 (15), 1899-1907, 2015
1272015
SIRT2 down‐regulation in HeLa can induce p53 accumulation via p38 MAPK activation‐dependent p300 decrease, eventually leading to apoptosis
Y Li, H Matsumori, Y Nakayama, M Osaki, H Kojima, A Kurimasa, H Ito, ...
Genes to Cells 16 (1), 34-45, 2011
1262011
A novel Snail-related transcription factor Smuc regulates basic helix–loop–helix transcription factor activities via specific E-box motifs
H Kataoka, T Murayama, M Yokode, S Mori, H Sano, H Ozaki, Y Yokota, ...
Nucleic acids research 28 (2), 626-633, 2000
1232000
Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer
N Matsumura, Z Huang, S Mori, T Baba, S Fujii, I Konishi, ES Iversen, ...
Genome research 21 (1), 74-82, 2011
1052011
Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects
CQ Wang, V Krishnan, LS Tay, DWL Chin, CP Koh, JY Chooi, GSS Nah, ...
Cell reports 8 (3), 767-782, 2014
1032014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20